Cargando…

Antibody-targeted paclitaxel loaded nanoparticles for the treatment of CD20(+) B-cell lymphoma

We developed a nano-antibody targeted chemotherapy (nATC) delivery strategy in which tumor specific and clinically relevant antibodies (rituximab, anti-CD20) are non-covalently bound to the albumin scaffold of nab-paclitaxel (ABX). We define the nanoparticle formed when the 2 drugs are bound (AR160)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nevala, Wendy K., Butterfield, John T., Sutor, Shari L., Knauer, Daniel J., Markovic, Svetomir N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381215/ https://www.ncbi.nlm.nih.gov/pubmed/28378801 http://dx.doi.org/10.1038/srep45682

Ejemplares similares

Identification of a peptide-peptide binding motif in the coating of nab-paclitaxel nanoparticles with clinical antibodies: bevacizumab, rituximab, and trastuzumab
por: Butterfield, John T., et al.
Publicado: (2017)

Identification of novel, immune-mediating extracellular vesicles in human lymphatic effluent draining primary cutaneous melanoma
por: Maus, Rachel L.G., et al.
Publicado: (2019)

Expansion of CD16-Negative Natural Killer Cells in the Peripheral Blood of Patients with Metastatic Melanoma
por: Holtan, Shernan G., et al.
Publicado: (2011)

Immune Reactivation by Cell-Free Fetal DNA in Healthy Pregnancies Re-Purposed to Target Tumors: Novel Checkpoint Inhibition in Cancer Therapeutics
por: Enninga, Elizabeth Ann L., et al.
Publicado: (2015)

The immunomodulatory effects of bevacizumab on systemic immunity in patients with metastatic melanoma
por: Mansfield, Aaron S., et al.
Publicado: (2013)

The Enhanced Cytotoxic Effects in B-Cell Leukemia and Lymphoma Following Activation of Prostaglandin EP4 Receptor and Targeting of CD20 Antigen by Monoclonal Antibodies
por: Markovič, Tijana, et al.
Publicado: (2022)

Fetal Sex-Based Differences in Maternal Hormones, Angiogenic Factors, and Immune Mediators During Pregnancy and the Postpartum Period
por: Enninga, Elizabeth Ann L, et al.
Publicado: (2015)

Contraction of T cell richness in lung cancer brain metastases
por: Mansfield, Aaron S., et al.
Publicado: (2018)

A prospective evaluation of the role of Vascular Endothelial Growth Factor (VEGF) and the immune system in stage III/IV melanoma
por: Agostino, Nicole Marie, et al.
Publicado: (2015)

Novel CD20 monoclonal antibodies for lymphoma therapy
por: Cang, Shundong, et al.
Publicado: (2012)

Monoclonal antibodies targeting CD20
por: Chang, Chien-Hsing, et al.
Publicado: (2013)

COVID‑19 antibody production by vaccination in chemotherapy with CD20 antibody for B‑cell lymphoma
por: Tsutsumi, Yutaka, et al.
Publicado: (2023)

Radioimmunotherapy of B-cell lymphoma with radiolabelled anti-CD20 monoclonal antibodies
por: Dillman, R. O.
Publicado: (2006)

Growth Modeling of the Maternal Cytokine Milieu throughout Normal Pregnancy: Macrophage-Derived Chemokine Decreases as Inflammation/Counterregulation Increases
por: Holtan, Shernan G., et al.
Publicado: (2015)

Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)–paclitaxel nanoparticles
por: Yang, Danbo, et al.
Publicado: (2011)

Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy
por: Cao, Xi, et al.
Publicado: (2020)

Endogenous Heat‐Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma
por: Domingo‐Musibay, Evidio, et al.
Publicado: (2017)

The targeting imaging and treatment capacity of gelsolin-targeted and paclitaxel-loaded PLGA nanoparticles in vitro and in vivo
por: Ji, Jiamei, et al.
Publicado: (2022)

Response to: Monoclonal antibodies targeting CD20
por: Klein, Christian, et al.
Publicado: (2013)

In vitro and in vivo targeting effect of folate decorated paclitaxel loaded PLA–TPGS nanoparticles
por: Thu, Ha Phuong, et al.
Publicado: (2015)

Growth Inhibition of CD20‐positive B Lymphoma Cell Lines by IDEC‐C2B8 Anti‐CD20 Monoclonal Antibody
por: Taji, Hirohumi, et al.
Publicado: (1998)

Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group
por: Wada, Naoki, et al.
Publicado: (2009)

Targeting CD83 in mantle cell lymphoma with anti‐human CD83 antibody
por: Li, Ziduo, et al.
Publicado: (2020)

Evidence of Th2 polarization of the sentinel lymph node (SLN) in melanoma
por: Grotz, Travis E, et al.
Publicado: (2015)

Generation of CD20-specific TCRs for TCR gene therapy of CD20(low) B-cell malignancies insusceptible to CD20-targeting antibodies
por: Jahn, Lorenz, et al.
Publicado: (2016)

Investigation of Effective Parameters on Size of Paclitaxel Loaded PLGA Nanoparticles
por: Madani, Fatemeh, et al.
Publicado: (2018)

Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
por: Pandya, Abhilash D, et al.
Publicado: (2019)

MDR1 siRNA loaded hyaluronic acid-based CD44 targeted nanoparticle systems circumvent paclitaxel resistance in ovarian cancer
por: Yang, Xiaoqian, et al.
Publicado: (2015)

Substance P-modified human serum albumin nanoparticles loaded with paclitaxel for targeted therapy of glioma
por: Ruan, Chunhui, et al.
Publicado: (2018)

Paclitaxel-Loaded Folate-Targeted Albumin-Alginate Nanoparticles Crosslinked with Ethylenediamine. Synthesis and In Vitro Characterization
por: Martínez-Relimpio, Ana María, et al.
Publicado: (2021)

Human Melanoma-Derived Extracellular Vesicles Regulate Dendritic Cell Maturation
por: Maus, Rachel L. G., et al.
Publicado: (2017)

Enhanced in vitro antiproliferative effects of EpCAM antibody-functionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells
por: Mitra, Moutushy, et al.
Publicado: (2011)

Phase I study of chimeric anti-CD20 monoclonal antibody in Chinese patients with CD20-positive non-Hodgkin's lymphoma
por: Gui, Lin, et al.
Publicado: (2016)

Cancer immune control dynamics: a clinical data driven model of systemic immunity in patients with metastatic melanoma
por: Frisch, Harold P., et al.
Publicado: (2021)

United we stand: Double targeting of CD79B and CD20 in diffuse large B‐cell lymphoma
por: Tarantelli, Chiara, et al.
Publicado: (2022)

Development of a Bispecific Nanobody Targeting CD20 on B-Cell Lymphoma Cells and CD3 on T Cells
por: Liu, Yanlong, et al.
Publicado: (2022)

Generation of a canine anti-canine CD20 antibody for canine lymphoma treatment
por: Mizuno, Takuya, et al.
Publicado: (2020)

Anti-Lymphoma Efficacy Comparison of Anti-CD20 Monoclonal Antibody-Targeted and Non-Targeted Star-Shaped Polymer-Prodrug Conjugates
por: Lidický, Ondřej, et al.
Publicado: (2015)

Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles
por: Zhao, Dongmei, et al.
Publicado: (2010)

Magnetic targeting of paclitaxel-loaded poly(lactic-co-glycolic acid)-based nanoparticles for the treatment of glioblastoma
por: Ganipineni, Lakshmi Pallavi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_b5hg3j1uuvv2uptpd9ae8gv21r